Filing Details
- Accession Number:
- 0001179110-14-017273
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-12-01 17:15:22
- Reporting Period:
- 2014-11-26
- Filing Date:
- 2014-12-01
- Accepted Time:
- 2014-12-01 17:15:22
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1578845 | Actavis Plc | ACT | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1536778 | William Meury | 1 Grand Canal Square, Docklands Dublin 2 L2 00000 | See Remarks | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Ordinary Shares, Par Value $0.0001 | Acquisiton | 2014-11-26 | 7,083 | $90.06 | 86,489 | No | 4 | M | Direct | |
Ordinary Shares, Par Value $0.0001 | Disposition | 2014-11-26 | 4,550 | $269.14 | 81,939 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Ordinary Shares, Par Value $0.0001 | Stock Option (Right to Buy) | Disposition | 2014-11-26 | 7,083 | $0.00 | 7,083 | $90.06 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2014-12-13 | No | 4 | M | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $268.23 to $270.72, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- The option was fully vested and exercisable as of December 13, 2009.